Evidence map›Paper›PMID 41692817›Full record

ArticleScientific reports2026

DPAS: disease-associated peptide anomaly score for identifying pathogenic peptides via one-class learning.

Zoya Khalid, Razia Khalid, Osman Ugur Sezerman

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zoya KhalidDepartment of Biosciences, COMSATS University, Islamabad, Pakistan. Zoya.khalid@comsats.edu.pk.
Razia KhalidNational University of Computer and Emerging Sciences, NUCES, FAST, Islamabad, Pakistan.
Osman Ugur SezermanFaculty of Medicine, Department of Biostatistics and Medical Informatics, Acibadem University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting disease-associated peptides is a challenging task in bioinformatics, mostly hindered by the lack of reliable negative datasets, leading to biased predictions. In this study, we propose a one-class classification approach that focuses exclusively on positive-labeled data. We employed three classifiers namely One-Class Support Vector Machines (OCSVM), Isolation Forest, and Autoencoders to classify disease-associated peptides, with Autoencoders yielding the best results. The Autoencoders trained on the positive dataset effectively differentiated the inliers from outliers which is further evaluated by mean reconstruction errors. Our method combines various sequence based features together. This framework provides an efficient solution for predicting disease-associated peptides that also overcomes the traditional binary classification approaches. To enhance interpretability and peptide prioritization, we introduce a new scoring metric Disease Peptide Anomaly Score (DPAS) which combines model-derived anomaly scores with feature importance values obtained using SHAP (SHapley Additive exPlanations). DPAS facilitates the ranking of peptides based on their likelihood of being disease-associated, offering a robust and interpretable approach for peptide biomarker discovery.

Indexed as

Computational BiologyPeptidesAlgorithmsAutoencoderClassification AlgorithmsHumansPrediction AlgorithmsSupport Vector MachinePeptides

Identifiers

PMID41692817
PMCPMC12996630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.